WMA
GILD icon

Wealth Management Associates’s Gilead Sciences GILD Stock Holding History

Wealth Management Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$320K Sell
2,535
-50
-2% -$6.59K 0.09% 192
2026
Q1 		$360K Hold
2,585
– – 0.12% 146
2025
Q4 		$317K Buy
2,585
+285
+12% +$34.6K 0.11% 169
2025
Q3 		$255K Hold
2,300
– – 0.09% 194
2025
Q2 		$255K Buy
+2,300
New +$245K 0.1% 182
2021
Q3 		– Sell
-3,399
Closed -$234K – 197
2021
Q2 		$234K Sell
3,399
-630
-16% -$42.1K 0.13% 178
2021
Q1 		$260K Sell
4,029
-220
-5% -$14.2K 0.17% 146
2020
Q4 		$248K Sell
4,249
-180
-4% -$10.9K 0.16% 146
2020
Q3 		$280K Sell
4,429
-5,576
-56% -$387K 0.22% 117
2020
Q2 		$770K Buy
10,005
+1,494
+18% +$114K 0.65% 38
2020
Q1 		$636K Buy
+8,511
New +$588K 0.64% 38

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wealth Management Associates's GILD Position: Q2 2026 in Review

Wealth Management Associates reduced its Gilead Sciences (GILD) stake by 1.9% in Q2 2026, selling an estimated $6.59K and leaving 2,535 shares worth $320K. The position accounts for 0.09% of the portfolio, ranked #192.

Wealth Management Associates first reported a position in GILD in Q1 2020 and has held it in 11 quarters since. The position peaked at $770K in Q2 2020. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wealth Management Associates held 2,535 shares of Gilead Sciences worth $320K as of Q2 2026.
  • Wealth Management Associates sold 50 Gilead Sciences shares in Q2 2026, an estimated $6.59K.
  • Gilead Sciences made up 0.09% of Wealth Management Associates's portfolio in Q2 2026, its #192 holding.
  • Wealth Management Associates first reported a position in Gilead Sciences in Q1 2020 and has held it in 11 quarters since.
  • Wealth Management Associates's Gilead Sciences position peaked at $770K in Q2 2020.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wealth Management Associates's 13F filing for Q2 2026, filed 21 Jul 2026.